Plus   Neg

Cardiome Pharma Corp. (CRME) Has Jumped To A 6-Month High On Cipher Deal

Cardiome Pharma Corp. (CRME) announced Tuesday morning that it has agreed to sell its Canadian business portfolio to Cipher Pharmaceuticals Inc. (CPH.TO).

Cardiome Pharma has gapped open sharply higher this morning and is now up 0.61 at $2.18 on the highest volume of the year. The stock has leaped to a 6-month high.

For comments and feedback contact: editorial@rttnews.com

Business News

$5 And Under

0 Articles
Follow RTT